Milner Institute partners with Flagship Pioneering and Cambridge University Health Partners to accelerate biotech research and innovation

The Milner Therapeutics Institute (MTI) are delighted to announce a new collaboration with Flagship Pioneering and Cambridge University Health Partners (CUHP), to jointly advance breakthrough scientific research and technologies.

The collaboration will focus on research and innovation and will enable Flagship Pioneering’s ecosystem of more than 40 companies to partner with the Milner Therapeutics Institute and CUHP to access breakthrough science and technologies, clinical translation and trial support, and data assets and biosamples.

Through this new partnership, Flagship will gain access to exciting opportunities across other top organizations in the Cambridge life sciences ecosystem, including the Wellcome Sanger Institute, the MRC Laboratory of Molecular Biology, the Babraham Institute, University of Cambridge, the NIHR Cambridge Biomedical Research Centre, the NIHR Cambridge Clinical Research Facility, and the Cambridge University Hospitals NHS Trust.

Read the full press release on the Milner website.